Western Blot Buffers and Stock Solutions: Recipes, Compatibility, and Handling

A practical reference for lysis, inhibitor, sample, running, transfer, blocking, TBS/TBST, and membrane-stripping solutions.

Key answer: A western blot buffer is part of the assay design. Detergent strength determines which proteins are extracted and whether native complexes survive; inhibitors preserve labile modifications; transfer and blocking buffers affect recovery and background; and stripping chemistry can damage later epitopes. Use the recipes below as defined starting conditions, then verify pH, concentration, target compatibility, storage, and downstream performance in your own workflow.

How to use this buffer reference

Western blot buffers are not interchangeable. A buffer that extracts a membrane protein efficiently may disrupt an immunoprecipitation complex. A buffer that preserves a native epitope may leave a cytoskeletal or membrane-associated target in the insoluble fraction. A phosphatase inhibitor that protects a sample can also interfere with a planned phosphatase treatment. Decide what the next assay needs before preparing the stock.

The recipes in this guide are working formulations adapted from the public source protocol. They are starting points rather than universal specifications. Prepare solutions with appropriate water quality, record lot and date, verify pH at the stated temperature, and follow local chemical-safety procedures for acids, detergents, reducing agents, and volatile or toxic reagents.[1][2]

Choose a lysis buffer by target and assay

The first decision is whether the antibody recognizes the target after denaturation. If a native or conformational epitope is required, begin with a detergent-free or mild non-ionic detergent buffer. If the target is membrane-associated, aggregated, or strongly protein-bound, a stronger ionic detergent system may improve extraction but can destroy complexes or alter the epitope.

Target or experimentStarting buffer choiceReason and boundary
Whole-cell extractNP-40 buffer or RIPANP-40 is milder; RIPA extracts more aggressively but can disrupt protein–protein interactions.
Soluble cytoplasmic proteinTris-HCl bufferLow-detergent extraction can preserve native interactions and reduce detergent interference.
Cytoskeletal-bound proteinTris–Triton bufferCombines a non-ionic detergent with salts and phosphatase-related components; optimize for the cytoskeletal target.
Membrane-bound proteinNP-40 or RIPADetergent is needed to release many membrane proteins; use the mildest system that gives recovery.
Nuclear or mitochondrial targetRIPA or a validated subcellular-fraction protocolFractionation can enrich a weak target; whole-cell lysis may dilute it below detection.
Immunoprecipitation before western blotNon-ionic or detergent-free buffer when possibleRIPA contains ionic detergents that can disrupt complexes and reduce pull-down efficiency.

Detergent choice also affects downstream assays. SDS, sodium deoxycholate, high salt, reducing agents, EDTA, and phosphatase inhibitors can interfere with binding, enzymatic assays, or phosphatase treatment. Keep a record of the final detergent and inhibitor concentrations in every lysate.

Lysis buffer recipes

NP-40 buffer

  • 150 mM NaCl
  • 1.0% NP-40; 0.1% Triton X-100 can be used as a possible substitute when compatible
  • 50 mM Tris-HCl, pH 8.0
  • Fresh protease inhibitors

NP-40 is a common starting point for whole-cell and membrane-associated proteins. If insoluble material or aggregates retain too much target, compare with RIPA; if native interactions must be preserved, test a milder formulation first.

RIPA buffer

  • 50 mM Tris-HCl, pH 8.0
  • 150 mM NaCl
  • 1% NP-40
  • 0.5% sodium deoxycholate
  • 0.1% SDS
  • Protease inhibitors
  • Phosphatase inhibitors when appropriate for the planned experiment
  • 1 mM EDTA, optional

A 10% sodium deoxycholate stock can be prepared by dissolving 5 g in 50 mL; protect the stock from light. RIPA is efficient for whole-cell and membrane-bound proteins, but its ionic detergents can disrupt protein complexes and compromise immunoprecipitation or pull-down assays. Phosphatase inhibitors can also interfere with a later phosphatase treatment.

Tris-HCl buffer

  • 20 mM Tris-HCl, pH 7.5
  • Protease inhibitors

Use this low-detergent formulation when the target is soluble or when preserving native interactions is more important than extracting detergent-resistant material. Mechanical shearing may be needed for complete cell disruption.

Tris–Triton buffer for cytoskeletal-bound proteins

  • 10 mM Tris, pH 7.4
  • 100 mM NaCl
  • 1 mM EDTA
  • 1 mM EGTA
  • 1 mM NaF
  • 20 mM Na4P2O7
  • 2 mM Na3VO4
  • 1% Triton X-100
  • 10% glycerol
  • 0.1% SDS
  • 0.5% sodium deoxycholate

This formulation includes chelators and phosphatase-inhibiting components as well as detergents. Prepare it only when those components are compatible with the intended target and downstream assay.

Storage starting point: The source protocol states that these lysis buffers can be kept at 4°C for several weeks or divided into aliquots and stored at −20°C for up to a year. Treat this as a formulation- and laboratory-specific starting point. Add labile inhibitors fresh, validate stability, and discard material that shows precipitation, contamination, pH drift, or unexplained assay loss.

Protease and phosphatase inhibitors

Proteolysis, dephosphorylation, and denaturation begin as soon as lysis starts. Keep samples, buffers, and equipment on ice or at 4°C and add the relevant inhibitors immediately before lysis. Do not add every inhibitor by default: chelators can affect metalloproteases and metal-dependent assays, while phosphatase inhibitors may block a planned dephosphorylation step.

InhibitorTargets or activity affectedFinal concentrationStock and handling note
AprotininTrypsin, chymotrypsin, plasmin2 µg/mLDilute in water at 10 mg/mL; do not reuse thawed aliquots.
LeupeptinLysosomal proteases5–10 µg/mLDilute in water; do not reuse thawed aliquots.
Pepstatin AAspartic proteases1 µg/mLPrepare a 1 mM stock in methanol.
PMSFSerine and cysteine proteases1 mMDilute in ethanol; the source protocol permits reuse of the same aliquot, but confirm local stability practice.
EDTAMetalloproteases requiring Mg2+ or Mn2+5 mMPrepare a 0.5 M aqueous stock and adjust pH to 8.0.
EGTAMetalloproteases requiring Ca2+1 mMPrepare a 0.5 M aqueous stock and adjust pH to 8.0.
Sodium fluorideSerine/threonine phosphatases5–10 mMDilute in water; do not reuse once defrosted.
Sodium orthovanadateTyrosine phosphatases1 mMDilute in water; do not reuse once defrosted.
Sodium pyrophosphateSerine/threonine phosphatases20 mMDilute in water and verify compatibility with the target assay.

Protease-inhibitor cocktails can simplify preparation, but record the components and final concentrations when the experiment is intended to be reproducible. A cocktail’s label is not enough to infer its compatibility with a metal-dependent enzyme, phosphatase treatment, or immunoprecipitation.

Sodium orthovanadate preparation

Sodium orthovanadate preparation involves strong acid/base handling, boiling, and a fume-hood step. Follow the institutional chemical-safety assessment, use appropriate PPE, and do not prepare it outside an approved laboratory procedure.

  1. Prepare a 100 mM sodium orthovanadate solution in double-distilled water.
  2. Adjust the pH to 9.0 with HCl.
  3. Boil until the solution becomes colorless while minimizing evaporation with a loose cover.
  4. Cool to room temperature, then adjust to pH 9.0 again.
  5. Repeat the boil–cool–pH cycle until the pH remains at 9.0 after cooling.
  6. Restore the initial volume with water and aliquot at −20°C.
  7. Discard the stock if it turns yellow.

This is a preparation outline, not a substitute for local chemical handling instructions. Label the solution with concentration, pH, date, operator, and storage conditions.

Loading, running, transfer, and blocking buffers

BufferFinal compositionUse and compatibility note
2× Laemmli loading buffer4% SDS; 10% 2-mercaptoethanol; 20% glycerol; 0.004% bromophenol blue; 0.125 M Tris-HCl; pH 6.8.Denatures and adds density/tracking dye for SDS-PAGE. Reducing agents and heating can destroy conformational epitopes.
Tris–glycine–SDS running buffer25 mM Tris base; 190 mM glycine; 0.1% SDS; pH 8.3.Supports conventional SDS-PAGE; verify the gel system and pH before use.
Wet-transfer buffer25 mM Tris base; 190 mM glycine; 20% methanol; pH 8.3.For proteins above 80 kDa, the source protocol suggests testing 0.1% SDS; methanol and SDS alter transfer differently.
Semi-dry transfer buffer48 mM Tris; 39 mM glycine; 20% methanol; 0.04% SDS.Use with the validated semi-dry apparatus and stack; small changes can affect transfer efficiency.
Blocking buffer3–5% milk or BSA in TBS or TBST; TBST contains 0.1% Tween 20.Choose blocker according to antibody and target. Filter the blocking solution to reduce particles and spotting.

Laemmli’s SDS system and electrophoretic transfer are foundational to the conventional western blot workflow, but the exact gel, membrane, buffer, and transfer conditions remain apparatus- and target-dependent.[3][4]

TBS and TBST stock solutions

10× TBS, 1 L

The concentrated stock contains 200 mM Tris and 1,500 mM NaCl.

  • 24 g Tris base (formula weight 121.1 g/mol)
  • 88 g NaCl (formula weight 58.4 g/mol)
  • Dissolve in about 900 mL distilled water.
  • Adjust to pH 7.6 with 12 N HCl.
  • Bring to a final volume of 1 L with distilled water.

To prepare 1× TBS, mix 1 part 10× stock with 9 parts distilled water and verify pH 7.6 again. The final 1× composition is 20 mM Tris and 150 mM NaCl.

Alternative 10× TBS, 1 L

  • 24 g Tris-HCl (formula weight 157.6 g/mol)
  • 5.6 g Tris base (formula weight 121.1 g/mol)
  • 88 g NaCl (formula weight 58.4 g/mol)
  • Dissolve in about 900 mL distilled water.
  • The solution should be approximately pH 7.6 at room temperature; adjust with concentrated HCl or NaOH if necessary.
  • Bring to 1 L with distilled water, dilute 1:10 for 1× TBS, and verify pH again.

Using Tris-HCl together with Tris base reduces the volume of concentrated HCl required for neutralization. Record whether the stock used the all-Tris-base or mixed Tris-HCl/Tris-base formulation.

TBST, 1 L

  • 100 mL 10× TBS
  • 900 mL distilled water
  • 1 mL Tween 20

Tween 20 is viscous and can remain on pipette tips. A 10% Tween 20 solution can be easier to dispense, but recalculate the volume so that the final detergent concentration remains 0.1%.

Stock preparation, pH, storage, and compatibility

Control pointWhat to recordWhy it matters
pHTemperature, electrode calibration, buffer formulation, and final pH.Tris pH changes with temperature; a recipe’s pH is not independent of measurement conditions.
Final volumeBring to final volume after dissolving and pH adjustment.Adding water before pH adjustment can change the final concentration.
Stock versus working solutionConcentration, dilution factor, date, operator, and storage temperature.Prevents a concentrated stock from being mistaken for a working buffer.
Fresh inhibitorsInhibitor identity, stock solvent, aliquot history, and addition time.Activity and freeze–thaw tolerance differ among inhibitors.
Detergent compatibilityNP-40, Triton X-100, deoxycholate, SDS, Tween 20, and final percentage.Detergents affect extraction, antibody binding, transfer, IP, and enzyme activity.
StorageAliquot size, temperature, light protection, appearance, and expiry or review date.Repeated freeze–thaw, precipitation, light, and contamination can change performance.
Downstream assayWestern blot, IP, phosphatase treatment, enzyme assay, or native binding assay.A buffer that works for one readout may inhibit another.

Prepare enough buffer for the planned number of samples plus a small handling margin, but avoid making large volumes of unstable inhibitor-containing lysis buffer. Filter blocking solutions when the formulation permits, and inspect every stock for precipitation, cloudiness, color change, or microbial growth before use.

Membrane-stripping buffers

Stripping removes bound antibodies so a membrane can be reprobed. It is a compromise: a stronger stripping treatment may remove residual signal more completely but can reduce target retention or damage epitopes. If quantitative comparison is central, separate blots can be safer than repeated stripping.

Medium stripping buffer, 1 L

  • 15 g glycine
  • 1 g SDS
  • 10 mL Tween 20
  • Bring to 800 mL with distilled water and adjust to pH 2.2.
  • Bring to a final volume of 1 L with distilled water.

Harsh stripping buffer, 100 mL

Prepare and use under a fume hood according to institutional chemical-safety procedures.

  • 20 mL 10% SDS
  • 12.5 mL 0.5 M Tris-HCl, pH 6.8
  • 67.5 mL distilled water
  • Add 0.8 mL β-mercaptoethanol under the fume hood.

Before reprobing, verify that the previous signal is removed with an appropriate detection check, reblock the membrane, and include a control for signal loss. Strip strength, exposure, antibody affinity, and membrane type all influence the outcome.

Troubleshooting by observed pattern

Observed patternPossible buffer-related causesNext checks
Target remains in the pelletLysis detergent is too mild, mechanical disruption is incomplete, or the target is aggregated.Compare NP-40 with RIPA, inspect the pellet, test a fractionation workflow, and verify that the antibody recognizes the extracted form.
Native complex or IP signal is lostRIPA, SDS, deoxycholate, heat, reducing agents, or high salt disrupted the interaction.Use a milder or detergent-free buffer, reduce mechanical/chemical stress, and test input and flow-through controls.
Phospho-signal is weak or absentDelayed cooling, missing phosphatase inhibitors, repeated freeze–thaw, or an inhibitor that is incompatible or inactive.Prepare fresh inhibitor aliquots, shorten handling time, keep samples cold, and compare total target with phospho-target.
High background or spotsInadequate washing, contaminated or unfiltered blocking buffer, excess Tween, or overconcentrated antibody.Filter blocker, verify TBST composition, inspect buffer clarity, and titrate antibody and wash conditions.
Uneven transferIncorrect transfer buffer, wrong methanol/SDS balance, precipitation, or incompatible gel/membrane setup.Check pH and composition, inspect the post-transfer gel, and optimize for target size and membrane type.
Stripped membrane gives weak second signalHarsh stripping damaged the epitope or removed target protein, or residual detergent interfered with blocking.Use a milder strip, shorten exposure to the strip, include a post-strip target control, or run separate membranes.
Buffer precipitates or changes colorIncorrect pH, incompatible salts/detergents, repeated freeze–thaw, light exposure, contamination, or degraded inhibitor.Discard questionable stock, remake from weighed reagents, document pH and storage, and test a fresh aliquot.

Common questions

Can I use RIPA for every western blot?

No. RIPA is efficient but contains ionic detergents that can disrupt complexes and alter native epitopes. Choose the mildest buffer that extracts the target and supports the intended assay.

Should phosphatase inhibitors be added to every lysate?

No. Add them when preserving a phosphorylation state is part of the experiment. They can interfere with a planned phosphatase treatment and may be unnecessary for a total-protein measurement.

Why do TBS and TBST behave differently?

TBST contains Tween 20, which reduces nonspecific interactions and changes antibody washing behavior. Too little or too much detergent can change background and target retention.

Can I use the same transfer buffer for wet and semi-dry transfer?

Not automatically. The buffer compositions and current/voltage conditions are coupled to the apparatus. Use a validated system and verify transfer with a ladder or total-protein stain.

Is a harsh stripping buffer always better?

No. Stronger chemistry may remove antibody more completely while damaging epitopes or reducing target signal. Compare stripping efficiency with the signal obtained after reprobing.

References

  1. Begum H, Murugesan P, Tangutur AD. Western blotting: a powerful staple in scientific and biomedical research. Biotechniques. 2022;73:58–69. doi:10.2144/btn-2022-0003. PMID: 35775367.
  2. Sule R, Rivera G, Gomes AV. Western blotting (immunoblotting): history, theory, uses, protocol and problems. Biotechniques. 2023;75:99–114. doi:10.2144/btn-2022-0034. PMID: 36971113.
  3. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi:10.1038/227680a0. PMID: 5432063.
  4. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350–4354. doi:10.1073/pnas.76.9.4350. PMID: 388439.
  5. Taylor SC, Posch A. The design of a quantitative western blot experiment. Biomed Res Int. 2014;2014:361590. doi:10.1155/2014/361590. PMID: 24738055.
  6. Ghosh R, Gilda JE, Gomes AV. The necessity of and strategies for improving confidence in the accuracy of western blots. Expert Rev Proteomics. 2014;11:549–560. doi:10.1586/14789450.2014.939635. PMID: 25059473.
  7. Kroon C, Breuer L, Jones L, et al. Blind spots on western blots: assessment of common problems in western blot figures and methods reporting with recommendations to improve them. PLoS Biol. 2022;20:e3001783. doi:10.1371/journal.pbio.3001783. PMID: 36095010.
undefined

Freya

Freya is a technical support expert of enkilife, familiar with immunology and cell biology, and is committed to providing customers with high-quality product portfolio and technical support to help customers efficiently complete research.

   💬 WhatsApp